- Home
- LKFN vs MNKD Comparison
LKFN vs MNKD Comparison
Compare LKFN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LKFN | MNKD |
|---|---|---|
| Founded | 1872 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 1997 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LKFN | MNKD |
|---|---|---|
| Price | $59.29 | $6.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $67.00 | $10.08 |
| AVG Volume (30 Days) | 143.2K | ★ 2.8M |
| Earning Date | 01-23-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | N/A | ★ 23.47 |
| EPS | ★ 3.79 | 0.10 |
| Revenue | $248,271,000.00 | ★ $313,787,000.00 |
| Revenue This Year | $17.16 | $21.54 |
| Revenue Next Year | $3.98 | $22.21 |
| P/E Ratio | ★ $15.79 | $61.14 |
| Revenue Growth | 2.85 | ★ 17.43 |
| 52 Week Low | $50.00 | $3.38 |
| 52 Week High | $75.19 | $7.07 |
Technical Indicators
Market Signals| Indicator | LKFN | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 66.29 |
| Support Level | $57.98 | $5.59 |
| Resistance Level | $60.56 | $5.90 |
| Average True Range (ATR) | 1.45 | 0.19 |
| MACD | 0.26 | 0.06 |
| Stochastic Oscillator | 70.89 | 99.47 |
Price Performance
Historical ComparisonAbout LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.